Arcutis Biotherapeutics (ARQT) Gets a Buy From TD Cowen
Arcutis Biotherapeutics Analyst Ratings
Buy Rating Affirmed for Arcutis Biotherapeutics Following FDA Approval of Zoryve for Atopic Dermatitis
Arcutis Biotherapeutics Analyst Ratings
Upgraded Buy Rating and Price Target for Arcutis Biotherapeutics Amid Zoryve's Robust Sales Performance
Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV), Arcutis Biotherapeutics (ARQT) and TruBridge (TBRG)
Arcutis Biotherapeutics: Strong Prescription Growth Fuels Buy Rating
Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)
Buy Rating on Arcutis Biotherapeutics Bolstered by Projected Q1 Sales Beat and 2024 Upside Potential
Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics Analyst Ratings
Arcutis Biotherapeutics (ARQT) Gets a Hold From JonesTrading
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Arcutis Biotherapeutics (ARQT)
Buy Rating Affirmed for Arcutis Biotherapeutics as Zoryve Sales Surge and Market Position Strengthens
Arcutis Biotherapeutics Analyst Ratings